<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00937807</url>
  </required_header>
  <id_info>
    <org_study_id>ALS-8-09-A-401</org_study_id>
    <secondary_id>EUDRACT 2009-012810-29</secondary_id>
    <nct_id>NCT00937807</nct_id>
  </id_info>
  <brief_title>Hemodynamic Stability During Carotid Endarterectomy.Comparison of LENOXe™ (Xenon 100% v/v) Versus Sevoflurane</brief_title>
  <official_title>Hemodynamic Stability During Carotid Endarterectomy Under General Anesthesia in Elderly Patients: Comparison LENOXe™ (xénon 100% v/v) Versus SEVOFLURANE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Air Liquide Santé International</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Groupe Hospitalier Pitie-Salpetriere</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Air Liquide Santé International</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the hemodynamics effects of two usual hypnotic agents
      (LENOXe ™ (xenon 100 % v/v) and sevoflurane) during a general anesthesia for carotid
      endarterectomy in elderly patients. The hypothesis is that the use of the LENOXe ™ (xenon 100
      % v/v) allows to obtain per-operating hemodynamic stability non inferior than with
      sevoflurane.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2009</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">February 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Standard deviation of the values of systolic blood pressure (SBP)collected per-operatively every minutes(BIOPAC ® MP150) Values of SBP over or under thresholds during and out of the clamping period, if so vasopressive/ hypotensive treatment used</measure>
    <time_frame>Pre-op, every min from 1-90 min during maintenance phase</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>cardiovascular, general, hepatic and renal tolerance to xenon. Quality and time of awakening, recovery index (IR);Post-op pain (EVA)and consumption of analgesic; Inflammatory Syndrome (cytokine profile); Subjective comfort of the patient</measure>
    <time_frame>During the whole anesthetic procedure and the postoperating time until 24 hours after discharge from the recovery room / intensive care unit and return to the ward</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">84</enrollment>
  <condition>Hemodynamic Stability</condition>
  <arm_group>
    <arm_group_label>sévoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>hypnotic use in standard general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>LENOXe™ (xénon 100 % v/v)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Safety of use in terms of hemodynamic stability to the LENOXe™ (xénon 100 % v/v) within the framework of the carotid surgery on the old person</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>xenon</intervention_name>
    <description>Inhalational gas; dose allowed: 60 % Xenon; the duration of the treatment will be defined through anesthesia-time for a carotid surgery</description>
    <arm_group_label>LENOXe™ (xénon 100 % v/v)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sévoflurane</intervention_name>
    <description>Inhalation gas; dose allowed: 1,4 %; the duration of the treatment will be defined through anesthesia-time for a carotid surgery</description>
    <arm_group_label>sévoflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients &gt; 55 years, status ASA II

          -  Carotid endarterectomy elected surgery

          -  Signed informed consent

        Exclusion Criteria:

        Related to the patients:

          -  Histories of hypersensibility in both products used in the study

          -  uncontrolled arterial High Blood Pressure in the preoperative anaesthesia screening

          -  Severe cardiac failure (FEVG &lt; 30 %)

          -  Major lung or airways disease and\or required per-operating FiO2&gt; 35 %

          -  Elevated intracranial pressure

          -  Pregnancy, breast feeding

          -  Major protected, under supervision, under guardianship

          -  Every patient entering within the framework of the contraindications indicated to §4.3
             of the summary of the characteristics of tested products (LENOXe ™ (xenon 100 % v/v),
             sevoflurane)

        Related to the surgery:

          -  Controlateral carotid stenosis superior to 70 % and\or preoperative indication in the
             implementation per-operating of a carotid shunt

          -  Surgery realized within the framework of an emergency

          -  Combined Surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>55 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierre CORIAT, Pr</last_name>
    <role>Principal Investigator</role>
    <affiliation>groupe hospitalier Pitié-Salpêtrière</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Pitié-Salpêtrière</name>
      <address>
        <city>Paris</city>
        <zip>75013</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 9, 2009</study_first_submitted>
  <study_first_submitted_qc>July 10, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 13, 2009</study_first_posted>
  <last_update_submitted>June 29, 2010</last_update_submitted>
  <last_update_submitted_qc>June 29, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 30, 2010</last_update_posted>
  <responsible_party>
    <name_title>Catherine Billoët, MD</name_title>
    <organization>Air Liquide Santé International</organization>
  </responsible_party>
  <keyword>hemodynamic stability</keyword>
  <keyword>xenon</keyword>
  <keyword>carotid surgery</keyword>
  <keyword>general anesthesia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Xenon</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

